Acadia Healthcare (NASDAQ:ACHC) Shares Up 3.5% – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares rose 3.5% during trading on Wednesday . The company traded as high as $29.63 and last traded at $29.83. Approximately 136,794 shares traded hands during mid-day trading, a decline of 90% from the average daily volume of 1,333,360 shares. The stock had previously closed at $28.81.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on ACHC shares. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Barclays downgraded shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $43.00 to $35.00 in a report on Friday, February 28th. TD Cowen lowered their price objective on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a research note on Tuesday, January 7th. Cantor Fitzgerald reissued a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday, December 10th. Finally, KeyCorp reduced their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a report on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $52.19.

Acadia Healthcare Trading Up 1.6 %

The company’s 50-day moving average is $37.41 and its 200 day moving average is $45.60. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a market cap of $2.80 billion, a PE ratio of 9.88, a P/E/G ratio of 1.46 and a beta of 1.38.

Institutional Trading of Acadia Healthcare

Hedge funds have recently modified their holdings of the business. Wellington Management Group LLP lifted its stake in Acadia Healthcare by 0.7% in the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company’s stock worth $465,283,000 after acquiring an additional 76,490 shares in the last quarter. FMR LLC increased its holdings in shares of Acadia Healthcare by 257.9% in the 4th quarter. FMR LLC now owns 6,230,631 shares of the company’s stock valued at $247,045,000 after purchasing an additional 4,489,681 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of Acadia Healthcare by 18.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company’s stock worth $126,189,000 after purchasing an additional 486,395 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after purchasing an additional 454,044 shares during the period. Finally, State Street Corp grew its position in Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after purchasing an additional 95,613 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.